Who are MYMD's key supply-chain partners?

Map MyMD (MYMD)'s suppliers, customers, dependencies, and concentration risk.

What is MYMD's biggest supplier?

See MyMD (MYMD) top suppliers, their share of cost of goods sold, and geographic concentration risk.

See MyMD (MYMD) top customers, share of revenue, and end-market concentration risk.

$1.81

Last traded 2024-08-19 — delisted

NASDAQ · Healthcare · Biotechnology · $4.3M mcap · 2M float · 2.96% daily turnover

1 relationships

As Filer

counterparties named

As Counterparty

mentioned by others

2024-05-23

Earliest Filing

2024-05-23

Latest Filing

1 mentions

Other companies that named MYMD in their SEC 8-K filings.

Filed By	Relationship	Summary	Filing Date	SEC
PMCB PharmaCyte Biotech, Inc.	target	PharmaCyte Biotech, Inc. purchased Series G Convertible Preferred Stock, warrants, and registration rights from MyMD Pha	2024-05-23	View

Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR